Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (154)
Revolution Medicines, Inc. (RVMD)
Kim Lorence H. — Director
Shares
300
Price
$200.56
Total Value
$60.17K
Shares Held After
72,790
% of Holdings
0.4%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
1,099
Price
$10.24
Total Value
$11.25K
Shares Held After
366,529
% of Holdings
0.3%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
100,000
Price
$0.05
Total Value
$5.00K
Shares Held After
690,167
% of Holdings
14.5%
Quoin Pharmaceuticals, Ltd. (QNRX)
Carter Denise P. — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,709
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Myers Michael — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,713
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Lawlor Sally Bridget — Chief Financial Officer
Shares
10,244
Price
$4.88
Total Value
$49.99K
Shares Held After
10,684
% of Holdings
95.9%
Quoin Pharmaceuticals, Ltd. (QNRX)
Culverwell Anthony James — Director
Shares
6,146
Price
$4.88
Total Value
$29.99K
Shares Held After
40,364
% of Holdings
15.2%
NovaBridge Biosciences (NBP)
Xu Cong Claire — EVP, Clinical Development
Shares
3,282
Price
$0.79
Total Value
$2.59K
Shares Held After
304,201
% of Holdings
1.1%
Imunon, Inc. (IMNN)
Eylward Susan — General Counsel and Corp Sec
Shares
2,525
Price
$1.56
Total Value
$3.95K
Shares Held After
2,896
% of Holdings
46.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
28,188
Price
$106.20
Total Value
$2.99M
Shares Held After
114,024
% of Holdings
19.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
11,514
Price
$105.37
Total Value
$1.21M
Shares Held After
142,212
% of Holdings
7.5%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Smith Hunter C — Chief Financial Officer
Shares
23,072
Price
$104.59
Total Value
$2.41M
Shares Held After
153,726
% of Holdings
13.0%
FENNEC PHARMACEUTICALS INC. (FENC)
Sayad Pierre Sargis — Chief Medical Officer
Shares
12,000
Price
$12.18
Total Value
$146.16K
Shares Held After
9,519
% of Holdings
55.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
44,259
Price
$6.99
Total Value
$309.37K
Shares Held After
4,231,434
% of Holdings
1.0%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.24
Total Value
$526.80K
Shares Held After
377,820
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
10,000
Price
$70.24
Total Value
$702.40K
Shares Held After
58,555
% of Holdings
14.6%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
94,767
Price
$0.06
Total Value
$5.69K
Shares Held After
590,167
% of Holdings
16.1%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
33,818
Price
$36.44
Total Value
$1.23M
Shares Held After
1,599,154
% of Holdings
2.1%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
166,182
Price
$35.63
Total Value
$5.92M
Shares Held After
1,632,972
% of Holdings
9.2%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
46,620
Price
$1.35
Total Value
$62.94K
Shares Held After
735,701
% of Holdings
6.3%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,000
Price
$2.80
Total Value
$2.80K
Shares Held After
33,000
% of Holdings
2.9%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
700
Price
$60.98
Total Value
$42.68K
Shares Held After
2
% of Holdings
99.7%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
6,368
Price
$60.17
Total Value
$383.15K
Shares Held After
702
% of Holdings
90.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.81
Total Value
$344.05K
Shares Held After
520,000
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
20,113
Price
$68.42
Total Value
$1.38M
Shares Held After
515,000
% of Holdings
3.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$71.40
Total Value
$713.97K
Shares Held After
494,887
% of Holdings
2.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$27.58
Total Value
$206.82K
Shares Held After
26,250
% of Holdings
22.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$524.42
Total Value
$104.88K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
6
Price
$523.42
Total Value
$3.14K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$522.40
Total Value
$270.08K
Shares Held After
324,649
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$521.58
Total Value
$149.17K
Shares Held After
325,166
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
751
Price
$520.30
Total Value
$390.74K
Shares Held After
325,452
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$519.19
Total Value
$213.91K
Shares Held After
326,203
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$518.14
Total Value
$697.42K
Shares Held After
326,615
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$517.11
Total Value
$768.42K
Shares Held After
327,961
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,386
Price
$516.16
Total Value
$1.23M
Shares Held After
329,447
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$515.46
Total Value
$840.20K
Shares Held After
331,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$514.26
Total Value
$246.84K
Shares Held After
333,463
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$43.27
Total Value
$64.91K
Shares Held After
116,731
% of Holdings
1.3%
BIOVIE INC. (BIVI)
Chappell Amy Suzon — Director
Shares
727
Price
$2.16
Total Value
$1.57K
Shares Held After
727
% of Holdings
100.0%
BIOVIE INC. (BIVI)
KIM JOANNE WENDY — Chief Financial Officer
Shares
2,500
Price
$2.18
Total Value
$5.45K
Shares Held After
3,441
% of Holdings
72.7%
BIOVIE INC. (BIVI)
Palumbo Joseph M — Chief Medical Officer
Shares
4,843
Price
$2.16
Total Value
$10.46K
Shares Held After
6,036
% of Holdings
80.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
128
Price
$61.77
Total Value
$7.91K
Shares Held After
59,745
% of Holdings
0.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
13,485
Price
$60.21
Total Value
$811.93K
Shares Held After
59,873
% of Holdings
18.4%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
36,387
Price
$58.64
Total Value
$2.13M
Shares Held After
73,358
% of Holdings
33.2%
Showing 51–100 of 154 transactions (page 2 of 4)